News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Canyon Pharmaceuticals: Study Finds Desirudin Superior to Enoxaparin in Patients with Poor Kidney Function Undergoing Orthopedic Surgery


5/2/2011 8:44:34 AM

PARSIPPANY, N.J.--(BUSINESS WIRE)--Desirudin reduced major venous thromboembolism (VTE) and post-operative bleeding compared with the standard of care, enoxaparin, in patients with poor kidney function undergoing orthopedic surgery, according to a poster presented at the Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) meeting.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES